Try
DANAHER CORP /DE/
DHRUnited States
66 filed reports · 580 financial concepts · 41 earnings calls · 0 media appearances
Filed reports
66 reports · Jul 2016 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 129 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 31 | 6,507 | Jul 2016 to Jun 2026 |
| Current · 8-KSEC EDGAR | 25 | 112 | Apr 2020 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 10 | 7,235 | Dec 2016 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 26, 2026 | Jul 21, 2026 | 3 | Open |
| FY2026 Q2 | 10-Q | Jun 26, 2026 | Jul 21, 2026 | 408 | Open |
| FY2026 Q1 | 8-K | Mar 27, 2026 | Apr 21, 2026 | 10 | Open |
| FY2026 Q1 | 10-Q | Mar 27, 2026 | Apr 21, 2026 | 293 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 24, 2026 | 1,264 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Jan 28, 2026 | 10 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Jan 12, 2026 | 2 | Open |
| FY2025 Q3 | 8-K | Sep 26, 2025 | Oct 21, 2025 | 4 | Open |
| FY2025 Q3 | 10-Q | Sep 26, 2025 | Oct 21, 2025 | 348 | Open |
| FY2025 Q2 | 10-Q | Jun 27, 2025 | Jul 22, 2025 | 218 | Open |
| FY2025 Q2 | 8-K | Jun 27, 2025 | Jul 22, 2025 | 4 | Open |
| FY2025 Q1 | 10-Q | Mar 28, 2025 | Apr 22, 2025 | 217 | Open |
Financial data
580 concepts · 13,854 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial544 concepts · 10,917 facts · Dec 2014 to Jul 2026
- Accumulated other comprehensive income loss net of tax60 · Dec 2014 to Jun 2026
- Gross profit (US GAAP)58 · Dec 2014 to Jun 2026
- Net income loss58 · Dec 2014 to Jun 2026
- Operating income loss58 · Dec 2014 to Jun 2026
- Revenue58 · Dec 2014 to Jun 2026
- Comprehensive income net of tax57 · Dec 2014 to Jun 2026
- Cost of goods and services sold (US GAAP)57 · Dec 2014 to Jun 2026
- Income tax expense benefit57 · Dec 2014 to Jun 2026
- Incremental common shares attributable to share based payment arrangements57 · Dec 2014 to Jun 2026
- Investment income interest57 · Dec 2014 to Jun 2026
- Other comprehensive income loss foreign currency transaction and translation adjustment net of tax57 · Dec 2014 to Jun 2026
- Other comprehensive income loss net of tax57 · Dec 2014 to Jun 2026
- Other comprehensive income loss pension and other postretirement benefit plans adjustment net of tax57 · Dec 2014 to Jun 2026
- Research and development expense57 · Dec 2014 to Jun 2026
- Selling general and administrative expense57 · Dec 2014 to Jun 2026
- Allocated share based compensation expense56 · Dec 2014 to Jun 2026
- Allocated share based compensation expense net of tax56 · Dec 2014 to Jun 2026
- Depreciation56 · Dec 2014 to Jun 2026
- Employee service share based compensation tax benefit from compensation expense56 · Dec 2014 to Jun 2026
- Increase decrease in accounts payable56 · Dec 2014 to Jun 2026
- Increase decrease in accounts receivable56 · Dec 2014 to Jun 2026
- Increase decrease in inventories56 · Dec 2014 to Jun 2026
- Increase decrease in other accounts payable and accrued liabilities56 · Dec 2014 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets56 · Dec 2014 to Jun 2026
Segment23 concepts · 2,471 facts · Jul 2015 to Jun 2026
- Revenue1,183 · Jul 2015 to Jun 2026
- Revenue (excluding assessed tax)248 · Dec 2018 to Sep 2025
- Operating income loss204 · Jul 2015 to Jun 2026
- Goodwill195 · Dec 2015 to Jun 2026
- Total Assets88 · Dec 2015 to Jun 2026
- Operating Income79 · Oct 2015 to Sep 2025
- Segment expenditure addition to long lived assets53 · Dec 2021 to Jun 2026
- Amortization of intangible assets50 · Dec 2022 to Jun 2026
- Depreciation50 · Dec 2022 to Jun 2026
- Segment reporting other item amount50 · Dec 2022 to Jun 2026
- Goodwill foreign currency translation gain loss45 · Dec 2015 to Dec 2025
- Goodwill purchase accounting adjustments45 · Dec 2015 to Dec 2025
- Goodwill acquired during period42 · Dec 2015 to Dec 2024
- Asset impairment charges34 · Dec 2023 to Dec 2025
- Depreciation depletion and amortization34 · Dec 2015 to Dec 2023
- Property plant and equipment additions31 · Dec 2015 to Dec 2022
- Restructuring charges17 · Dec 2015 to Dec 2018
- Goodwill written off related to sale of business unit7 · Dec 2020 to Dec 2021
- Depreciation & Amortization4 · Dec 2015
- Goodwill impairment loss4 · Sep 2024 to Jun 2025
- Goodwill transfers4 · Dec 2022
- Environmental & Applied Solutions3 · Mar 2023 to Sep 2023
- Operating segments1 · Dec 2017
Geography4 concepts · 213 facts · Dec 2015 to Jun 2026
- Revenue180 · Mar 2018 to Jun 2026
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest26 · Dec 2015 to Dec 2025
- Pretax Income6 · Dec 2015 to Dec 2021
- Cash and Equivalents1 · Dec 2016
Product1 concepts · 130 facts · Dec 2014 to Jun 2026
- Revenue130 · Dec 2014 to Jun 2026
Guidance8 concepts · 123 facts · Apr 2020 to Jul 2026
- Revenue Growth Guidance63 · Apr 2020 to Jul 2026
- Effective Tax Rate Guidance16 · Oct 2025 to Jul 2026
- EPS (Diluted) Guidance14 · Apr 2025 to Jul 2026
- Revenue Growth Guidance (Base business; Adjusted (non-GAAP))12 · Jan 2022 to Oct 2022
- Operating Margin Guidance6 · Jan 2026 to Jul 2026
- Revenue Growth Guidance (core sales; Adjusted (non-GAAP))6 · Jan 2022 to Jan 2023
- Revenue Growth Guidance (Adjusted (non-GAAP))4 · Oct 2022
- Revenue Growth Guidance (Base business core sales; Adjusted (non-GAAP))2 · Jan 2023
Segments
2,814 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments23 members · 2,471 facts
- Diagnostics544 · Dec 2015 to Jun 2026
- Life Sciences538 · Dec 2015 to Jun 2026
- Environmental Applied Solutions318 · Dec 2015 to Sep 2023
- Biotechnology302 · Dec 2020 to Jun 2026
- Life sciences segment236 · Oct 2015 to Jun 2026
- Diagnostics segment232 · Oct 2015 to Jun 2026
- Dental128 · Jul 2015 to Sep 2019
- Environmental applied solutions62 · Oct 2015 to Sep 2023
- Biotechnology segment44 · Dec 2021 to Jun 2026
- Dental29 · Dec 2015 to Jun 2019
- Dental envista4 · Dec 2018 to Sep 2019
- Diagnostics4 · Dec 2015 to Dec 2018
- Life sciences4 · Dec 2015 to Dec 2018
- Environmental4 · Jul 2015 to Jul 2016
- Industrial Technologies4 · Jul 2015 to Jul 2016
- Life Sciences And Diagnostics4 · Jul 2015 to Jul 2016
- Test And Measurement4 · Jul 2015 to Jul 2016
- Environmental2 · Dec 2015 to Jul 2016
- Industrial technologies2 · Dec 2015 to Jul 2016
- Life sciences and diagnostics2 · Dec 2015 to Jul 2016
- Test and measurement2 · Dec 2015 to Jul 2016
- All Segments Excluding Molecular Diagnostic Product Line1 · Dec 2017
- Life Sciences Biotechnology And Diagnostics1 · Dec 2025
Statement geographicalsrt:StatementGeographicalAxis6 members · 188 facts
- High Growth Markets42 · Mar 2018 to Jun 2026
- North America42 · Mar 2018 to Jun 2026
- Other Developed Markets42 · Mar 2018 to Jun 2026
- Western Europe42 · Mar 2018 to Jun 2026
- Non Us10 · Dec 2016 to Dec 2025
- US10 · Dec 2016 to Dec 2025
Product or servicesrt:ProductOrServiceAxis6 members · 108 facts
- Revenuefrom Contractwith Customer Measurement Nonrecurring42 · Mar 2018 to Jun 2026
- Revenuefrom Contractwith Customer Measurement Recurring42 · Mar 2018 to Jun 2026
- Analytical And Physical Instrumentation7 · Dec 2016 to Dec 2022
- Product Identification7 · Dec 2016 to Dec 2022
- Researchandmedicalproducts7 · Dec 2016 to Dec 2022
- Dentalproducts3 · Dec 2016 to Dec 2018
Statement geographicalus-gaap:StatementGeographicalAxis8 members · 25 facts
- Non us4 · Dec 2015 to Dec 2021
- Us3 · Dec 2015 to Dec 2021
- High Growth Markets3 · Mar 2018 to Sep 2018
- Non Us3 · Dec 2015 to Dec 2017
- North America3 · Mar 2018 to Sep 2018
- Other Developed Markets3 · Mar 2018 to Sep 2018
- US3 · Dec 2015 to Dec 2017
- Western Europe3 · Mar 2018 to Sep 2018
Product or serviceus-gaap:ProductOrServiceAxis6 members · 22 facts
- Analytical And Physical Instrumentation4 · Dec 2014 to Dec 2017
- Dentalproducts4 · Dec 2014 to Dec 2017
- Product Identification4 · Dec 2014 to Dec 2017
- Researchandmedicalproducts4 · Dec 2014 to Dec 2017
- Nonrecurring3 · Mar 2018 to Sep 2018
- Recurring3 · Mar 2018 to Sep 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary52 claims from 10 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary211 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes10 claims from 1 reports · Dec 2025
- Risk factors87 risks from 2 annual reports · 2024 to 2025
Earnings calls
41 calls · Jul 2016 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 21, 2026
- FY2026 Q1Apr 21, 2026
- FY2025 Q4Jan 28, 2026
- FY2025 Q3Oct 21, 2025
- FY2025 Q2Jul 22, 2025
- FY2025 Q1Apr 22, 2025
- FY2024 Q4Jan 29, 2025
- FY2024 Q3Oct 22, 2024
- FY2024 Q2Jul 23, 2024
- FY2024 Q1May 14, 2024
- FY2023 Q4Jan 30, 2024
- FY2023 Q3Oct 24, 2023
- FY2023 Q2Jul 25, 2023
- FY2023 Q1Apr 25, 2023
- FY2022 Q4Jan 24, 2023
- FY2022 Q3Oct 20, 2022
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.